Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin vs Lobaplatin in HIPEC for Advanced Colorectal Cancer
NCT04845490Phase 2Not yet recruiting
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of mitomycin c, lobaplatin in colorectal cancer (CRC). Planned start Sep 2022; status: not yet recruiting.
02
Drugs
mitomycin clobaplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04845490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04845490.